Aligos Therapeutics (ALGS) Insider Trading & Ownership $7.46 +0.18 (+2.47%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$7.47 +0.01 (+0.13%) As of 08/1/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Aligos Therapeutics (NASDAQ:ALGS) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage4.80%Number OfInsiders Buying(Last 3 Years)1Amount OfInsider Buying(Last 3 Years)$6.03MNumber OfInsiders Selling(Last 3 Years)0 Get ALGS Insider Trade Alerts Want to know when executives and insiders are buying or selling Aligos Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ALGS Insider Buying and Selling by Quarter Aligos Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails10/25/2023Carole NuechterleinDirectorBuy317,344$19.00$6,029,536.00 (Data available from 1/1/2013 forward) ALGS Insider Trading Activity - Frequently Asked Questions Who is on Aligos Therapeutics' Insider Roster? The list of insiders at Aligos Therapeutics includes Carole Nuechterlein. Learn more on insiders at ALGS. What percentage of Aligos Therapeutics stock is owned by insiders? 4.80% of Aligos Therapeutics stock is owned by insiders. Learn more on ALGS's insider holdings. Which Aligos Therapeutics insiders have been buying company stock? The following insider purchased ALGS shares in the last 24 months: Carole Nuechterlein ($6,029,536.00). How much insider buying is happening at Aligos Therapeutics? Insiders have purchased a total of 317,344 ALGS shares in the last 24 months for a total of $6,029,536.00 bought. Aligos Therapeutics Key ExecutivesDr. Lawrence M. Blatt MBA (Age 62)Ph.D., CEO, President & Chairman of the Board Compensation: $1.03MDr. Julian A. Symons DPHIL (Age 62)Executive VP & Chief Scientific Officer Compensation: $735.51kDr. Matthew W. McClure M.D. (Age 52)Executive VP & Chief Medical Officer Compensation: $740.39kKristina EngesethVP and Head of People & CultureDr. Sushmita M. Chanda DABT (Age 57)Ph.D., Executive Vice President & Chief Development Officer Dr. David B. Smith Ph.D.Executive VP & Head of Chemical OperationsDr. Tse-I Lin Ph.D.VP of Early Compound Development & Belgian Site Head More Insider Trading Tools from MarketBeat Related Companies RAPT Insider Ownership DMAC Insider Ownership YMAB Insider Ownership NLTX Insider Ownership CRBU Insider Ownership FDMT Insider Ownership ALMS Insider Ownership CRGX Insider Ownership TVGN Insider Ownership CTMX Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles The Bottom Is in For These 3 Small-Cap Stocks Insiders Are Buying3 Catalysts Driving Plug Power’s Turnaround CaseInsider Selling Hits Market Leaders—Should You Be Worried?Insiders Spent Millions on These 3 Stocks Over the Past 2 Months3 Small Caps Drawing Insider and Institutional Support This page (NASDAQ:ALGS) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important update...InvestorPlace | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredA new rule goes live in July — and the banks are quietly crushing itA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aligos Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aligos Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ALGS Stock Alerts